Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 558 across all filing types
Latest filing 2024-04-12 Investor Presentation
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
Novogene 2024 Corporate Value and Return Enhancement Action Plan
Investor Presentation Classification · 95% confidence The document is titled 'Novogene Corporate Value and Return Enhancement Action Plan 2024' and contains detailed strategic plans, operational improvements, governance enhancements, investor communication strategies, and financial return initiatives such as dividend distribution and share repurchase plans. It discusses the company's systematic construction, innovation, governance, and long-term development plans rather than presenting actual financial statements or quarterly/yearly financial results. There is no indication of this being an official annual or interim financial report, audit report, earnings release, or regulatory filing. The content is focused on strategic planning and value enhancement actions for the upcoming year, which aligns with a management or corporate strategic plan rather than a formal financial report. Given the nature of the content, the best fitting category is Investor Presentation (IP), as it is a detailed presentation for investors focusing on financials, strategy, and market position, which matches the document's content and purpose.
2024-04-12 Chinese
北京诺禾致源科技股份有限公司2023年内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2023 年度内部控制评价报告' which translates to '2023 Annual Internal Control Evaluation Report'. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2023, including financial and non-financial internal control defects, their identification standards, and rectification status. The document is a detailed report on internal control evaluation, which is a type of audit-related report but not a full annual report (10-K). It contains substantive evaluation content and conclusions about internal controls, which aligns with the definition of an Audit Report / Information (AR). The document length is 4363 characters, which is sufficient to contain detailed evaluation content rather than just an announcement. There is no indication that this is a certification letter or a brief announcement. Therefore, the document fits best under the Audit Report / Information (AR) category.
2024-04-12 Chinese
北京诺禾致源科技股份有限公司第三届监事会第十四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Beijing Nuohe Zhiyuan Technology Co., Ltd. It details the approval of various company reports and proposals including the 2023 annual supervisory board work report, 2023 annual financial settlement report, 2023 profit distribution plan, 2023 annual report and summary, and 2024 first quarter report. The document also mentions that these reports and proposals will be submitted to the shareholders' meeting for approval. The document is a formal announcement of the resolutions passed in a board meeting rather than the reports themselves. It references the actual reports being disclosed on the Shanghai Stock Exchange website separately. The document length is about 5262 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement of board resolutions and report approvals, not the full reports themselves.
2024-04-12 Chinese
北京诺禾致源科技股份有限公司关于终止部分募投项目并将剩余募集资金用于新投资项目的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Beijing Nuohe Zhiyuan Technology Co., Ltd. regarding the termination of part of a fundraising investment project and the reallocation of remaining raised funds to a new investment project. It details the original fundraising, the terminated project, the new project, investment amounts, approvals by the board and supervisory committee, and the need for shareholder approval. The document references regulatory approvals and compliance with securities laws and stock exchange rules. It is a formal disclosure about changes in the use of raised capital, not a full financial report or earnings release. It fits the definition of a Capital/Financing Update (CAP) as it updates on company fundraising and capital structure changes, specifically the reallocation of raised funds. The document length and content confirm it is not a brief announcement or a report publication announcement, but a substantive update on capital use.
2024-04-12 Chinese
北京诺禾致源科技股份有限公司2023年度非经营性资金占用及其他关联资金往来情况专项报告
Audit Report / Information Classification · 95% confidence The document is titled as a "专项报告" (special report) concerning "非经营性资金占用及其他关联资金往来情况" (non-operating fund occupation and other related party fund transactions) for the year 2023. It references an audit report issued on April 12, 2024, and includes detailed financial data about related party transactions and fund usage. The document is not a full annual report (10-K), nor is it an earnings release or interim report. It is a standalone audit-related report focusing on a specific regulatory requirement about related party fund transactions, referencing regulatory guidelines from the China Securities Regulatory Commission and Shanghai Stock Exchange. The document contains substantive financial data and analysis related to the audit of these transactions, which aligns with the definition of an Audit Report / Information (AR). It is not merely an announcement or certification, but a detailed report on a specific audit subject matter.
2024-04-12 Chinese
北京诺禾致源科技股份有限公司2023年年度利润分配方案公告
Notice of Dividend Amount Classification · 95% confidence The document is a formal announcement from Beijing Nuohe Zhiyuan Technology Co., Ltd. regarding the 2023 annual profit distribution plan. It details the cash dividend per share, total dividend amount, reasons for the dividend payout ratio being below 30%, and the company's financial performance and future plans. It also mentions that the plan will be submitted to the 2023 annual shareholders' meeting for approval. The document is relatively short (3110 characters) and focuses on dividend distribution details rather than presenting full financial statements or comprehensive annual report content. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and related details for shareholders.
2024-04-12 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.